Tissue factor and factor VIIa cross-species compatibility.

Area of Science:

• Biochemistry and Molecular Biology
• Hematology
• Pharmacology

Background:

• Species compatibility knowledge is essential for interpreting in vivo and in vitro experimental data involving human proteins.
• The prothrombin time (PT) assay historically contributed to understanding cross-species tissue factor (TF) and coagulation factor VII (FVII) compatibility.
• Advancements in recombinant protein expression and amino acid substitution have expanded cross-species TF-FVIIa research.

Purpose of the Study:

• To review and compare findings on human TF-FVIIa complex interactions with those from non-human species.
• To highlight how cross-species studies enhance understanding of the human TF-FVIIa complex's structure and function.
• To identify challenges and insights gained from studying TF-FVIIa interactions across different species.

Main Methods:

• Review of existing literature on TF and FVII from various species (cattle, dog, rabbit, mouse, rat, zebrafish).
• Characterization of purified recombinant TF and/or FVIIa from different species.
• Analysis of intermolecular interactions and biological effects of TF-FVIIa complex formation.

Main Results:

• Purified and characterized TF and/or FVIIa from cattle, dog, rabbit, mouse, rat, and zebrafish.
• Cross-species studies provide insights into species-specific TF-FVIIa interactions.
• Data from non-human TF-FVIIa systems contribute to understanding the human TF-FVIIa complex.

Conclusions:

• Cross-species TF-FVIIa research is crucial for interpreting experimental data and understanding human coagulation.
• Studying TF and FVIIa from different species advances general knowledge of the human TF-FVIIa complex.
• Careful consideration of species differences is necessary when extrapolating findings across borders.